Longeveron LLC
Price & Volume
Stats
See moreOpen | $1.69 |
Previous Close | $1.70 |
Day Range | $1.58-$1.72 |
52W Range | $0.77-$6.40 |
Market Cap | $22.7M |
Shares Short | 518,880 |
Financials
See moreRevenue (12 Mos) | $1.8M |
Revenue Growth (YoY) | 415.3% |
Gross Profit (12 Mos) | $1.3M |
Diluted EPS | -$5.62 |
News
See moreYahoo Finance • 18 days ago
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease
Yahoo Finance • 24 days ago
Longeveron® to Present at the 37th Annual Roth Conference
Yahoo Finance • 28 days ago
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
Yahoo Finance • last month
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
About
CEO | Mr. Mohamed Wa'el Ahmed Hashad M.B.A. |
CFO | Ms. Lisa A. Locklear M.B.A. |
Address | Life Science & Technology Park, Miami, FL, United States, 33136 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |
